Glabellar Frown Lines
📧 Sign up to get email alerts when something new happens for Glabellar Frown Lines.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002 [Phase 3]
Phase III trial evaluating DWP-450 for safety and efficacy in treating glabellar lines has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006 [Phase 2]
Phase 2 safety study of DWP-450 (Botulinum toxin type A) for glabellar lines has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines [Phase 2]
Phase 2 safety study of DWP-450 (Botulinum purified neurotoxin type A) for treating glabellar lines completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Safety and Efficacy Study of Dysport RU and Glabellar Lines [Phase 2]
Phase 2 trial updating safety and efficacy for Dysport RU in treating glabellar frown lines; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2012-11-26Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines [NA]
Safety and efficacy results from a completed clinical trial evaluating botulinum toxin type A for forehead and frown lines.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines [Phase 3]
Phase 3 study comparing NT 201 (Xeomin/Bocouture) with botulinum toxin type A for treating glabellar frown lines; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines [Phase 3]
Phase 3 trial comparing incobotulinumtoxinA (Xeomin) to placebo for the treatment of glabellar frown lines has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines [Phase 3]
Phase 3 trial comparing Xeomin (incobotulinumtoxinA) to placebo for moderate to severe glabellar frown lines has completed. Results were pos…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines [Phase 2]
This Phase 2 trial conducted by Merz Pharmaceuticals identified the optimal dose of NT 201 for treating glabellar frown lines.